Skip to main content

Table 5 Correlation between OS and clinical-pathological data in a multivariate analysis

From: Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study

 

HR

95%CI

p

Age (years)

Range (26–74)

Median: 49.5

  < 50

   

  ≥ 50

1.2

0.7–2.3

0.5

VD level

  < 20 ng/mL

   

  ≥ 20 ng/mL

1.03

0.6–1.8

0.9

Clinical stage

 I-II

   

 III

2.8

1.6–5.0

0.001

Tumor subtypes

 HER2+

1.77

0.8–4.1

0.1

 HR+/HER2-

   

 TNBC

6.5

3.1–13.7

0.0001

pCR

 no

   

 yes

0.2

0.09–0.5

0.001

SBR grade

 II

   

 III

0.86

0.5–1.6

0.6